Differential expression of extracellular matrix and adhesion molecule genes in the brain of juvenile versus adult mice in responses to intracerebroventricular administration of IL-1

NeuroImmunoModulation

Volumn 14, Issue 1, 2007, Pages 46-56

  Ching, San ^a,b   Zhang, Hao ^a   Chen, Qun ^a   Quan, Ning ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b 4187 Postle Hall ^*  (United States)

Author keywords

Adhesion molecules; Blood brain barrier; Cytokines; Extracellular matrix; Leukocyte infiltration; Microarray

Indexed keywords

CELL ADHESION MOLECULE; CONTACTIN; CONTACTIN 1; EXTRACELLULAR MATRIX PROTEIN 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; LAMININ; LAMININ ALPHA4; LAMININ BETA1 1; MATRIX METALLOPROTEINASE 17; PROCOLLAGEN; PROCOLLAGEN 4 ALPHA 1; SCLEROPROTEIN; STROMELYSIN; THROMBOSPONDIN; THROMBOSPONDIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; INJECTION; JUVENILE ANIMAL; LEUKOCYTE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

AGE FACTORS; ANIMALS; BRAIN; CELL ADHESION MOLECULES; CHEMOTAXIS, LEUKOCYTE; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; LEUKOCYTES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34548371790     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107288     Document Type: Article

References (45)

1. McKeating EG, Andrews PJ: Cytokines and adhesion molecules in acute brain injury. Br J Anaesth 1998;80:77-84.
2. McKeating EG, Andrews PJ, Mascia L: Leukocyte adhesion molecule profiles and outcome after traumatic brain injury. Acta Neurochir Suppl 1998;71:200-202.
3. Schiffenbauer J, Streit WJ, Butfiloski E, LaBow M, Edwards C 3rd, Moldawer LL: The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin Immunol 2000;95:117-123.
4. Ostergaard C, Yieng-Kow RV, Benfield T, Frimodt-Moller N, Espersen F, Lundgren JD: Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun 2000;68:3153-3157.
5. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 2000;165:2327-2330.
6. Patterson CE, Lawrence DM, Echols LA, Rall GF: Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and γ interferon dependent. J Virol 2002;76:4497-4506.
7. Bernardes-Silva M, Anthony DC, Issekutz AC, Perry VH: Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins. J Cereb Blood Flow Metab 2001;21:1115-1124.
8. Proescholdt MG, Chakravarty S, Foster JA, Foti SB, Briley EM, Herkenham M: Intracerebroventricular but not intravenous interleukin-1β induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 2002;112:731-749.
9. Ching S, He L, Lai W, Quan N: IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 2005;19:127-137.
10. Ching S, Zhang H, Lai W, Quan N: Peripheral injection of lipopolysaccharide prevents brain recruitment of leukocytes induced by central injection of interleukin-1. Neuroscience 2006;137:717-726.
11. Abbott NJ: Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000;20:131-147.
12. Quan N, Herkenham M: Connecting cytokines and brain: a review of current issues. Histol Histopathol 2002;17:273-288.
13. Maslin CL, Kedzierska K, Webster NL, Muller WA, Crowe SM: Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection. Curr HIV Res 2005;3:303-317.
14. Danton GH, Dietrich WD: Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 2003;62:127-136.
15. Greenwood J, Etienne-Manneville S, Adamson P, Couraud PO: Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul Pharmacol 2002;38:315-322.
16. Zameer A, Hoffman SA: Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J Neuroimmunol 2003;142:67-74.
17. Dunne JL, Collins RG, Beaudet AL, Ballantyne CM, Ley K: Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-α-induced inflammation. J Immunol 2003;171:6105-6111.
18. Ley K: Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002;186:8-18.
19. Piraino PS, Yednock TA, Freedman SB, Messersmith EK, Pleiss MA, Karlik SJ: Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of α4 integrin. Mult Scler 2005;11:683-690.
20. Danton GH, Dietrich WD: The search for neuroprotective strategies in stroke. AJNR Am J Neuroradiol 2004;25:181-194.
21. Gasche Y, Soccal PM, Kanemitsu M, Copin JC: Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 2006;11:1289-1301.
22. Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC: Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 2006;7:56.
23. Shigemori Y, Katayama Y, Mori T, Maeda T, Kawamata T: Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir Suppl 2006;96:130-133.
24. Vajtr D, Prusa R, Houst'ava L, Samal F, Kukacka J, Pachl J: Biochemical and immunohistochemical markers of brain injury (article in Czech). Soud Lek 2006;51:36-41.
25. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R: Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357-10364.
26. Gurney KJ, Estrada EY, Rosenberg GA: Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 2006;23:87-96.
27. Boz C, Ozmenoglu M, Velioglu S, Kilinc K, Orem A, Alioglu Z, Altunayoglu V: Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon β. Clin Neurol Neurosurg 2006;108:124-128.
28. Krizanac-Bengez L, Hossain M, Fazio V, Mayberg M, Janigro D: Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines. Am J Physiol Cell Physiol 2006;291:C740-749.
29. Anthony DC, Bolton SJ, Fearn S, Perry VH: Age-related effects of interleukin-1β on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997;120:435-444.
30. Bolton SJ, Perry VH: Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp Neurol 1998;154:231-240.
31. Campbell SJ, Wilcockson DC, Butchart AG, Perry VH, Anthony DC: Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1β-induced neutrophil recruitment. J Neurochem 2002;83:432-441.
32. Lawson LJ, Perry VH: The unique characteristics of inflammatory responses in mouse brain are acquired during postnatal development. Eur J Neurosci 1995;7:1584-1595.
33. Goldring SR, Goldring MB: The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004;427(suppl):S27-36.
34. Do MS, Jeong HS, Choi BH, Hunter L, Langley S, Pazmany L, Trayhurn P: Inflammatory gene expression patterns revealed by DNA microarray analysis in TNF-α-treated SGBS human adipocytes. Yonsei Med J 2006;47:729-736.
35. Falk J, Bonnon C, Girault JA, Faivre-Sarrailh C: F3/contactin, a neuronal cell adhesion molecule implicated in axogenesis and myelination. Biol Cell 2002;94:327-334.
36. Langle SL, Poulain DA, Theodosis DT: Neuronal-glial remodeling: a structural basis for neuronal-glial interactions in the adult hypothalamus. J Physiol Paris 2002;96:169-175.
37. Bizzoca A, Virgintino D, Lorusso L, Buttiglione M, Yoshida L, Polizzi A, Tattoli M, Cagiano R, Rossi F, Kozlov S, Furley A, Gennarini G: Transgenic mice expressing F3/contactin from the TAG-1 promoter exhibit developmentally regulated changes in the differentiation of cerebellar neurons. Development 2003;130:29-43.
38. De Benedictis L, Bizzoca A, Gennarini G: Transgenic models for studying expression and function of axonal adhesive glycoproteins. Arch Ital Biol 2005;143:179-190.
39. De Benedictis L, Bizzoca A, Corsi P, Albieri I, Consalez GG, Gennarini G: Activation profile of the F3/Contactin gene in the developing mouse cerebellum. Mol Cell Neurosci 2006;32:403-418.
40. Schiller M, Javelaud D, Mauviel A: TGF-β-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 2004;35:83-92.
41. Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, Pennington CJ, Bourgoin P, Edwards DR, Yong VW: Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 2003;126:2738-2749.
42. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T: Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003;253:269-285.
43. Kanesaka T, Mori M, Hattori T, Oki T, Kuwabara S: Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006;77:185-188.
44. Gauthier MC, Racine C, Ferland C, Flamand N, Chakir J, Tremblay GM, Laviolette M: Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils. Int J Biochem Cell Biol 2003;35:1667-1673.
45. Rahkonen OP, Koskivirta IM, Oksjoki SM, Jokinen E, Vuorio EI: Characterization of the murine Timp4 gene, localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA. Biochim Biophys Acta 2002;1577:45-52.